+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dihydropyridine"

From
From
Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2025 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Critical Care Antiarrhythmic Drugs Market Report 2025 - Product Thumbnail Image

Critical Care Antiarrhythmic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Lipid Regulators Market Report 2025 - Product Thumbnail Image

Lipid Regulators Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Dihydropyridine is a class of drugs used in the treatment of cardiovascular diseases. These drugs are used to treat hypertension, angina, and congestive heart failure. They work by blocking the action of calcium channels in the heart and blood vessels, which helps to reduce blood pressure and improve blood flow. Dihydropyridine drugs are generally well tolerated and have few side effects. Dihydropyridine drugs are widely used in the treatment of cardiovascular diseases, and are available in both generic and branded forms. They are available in both oral and intravenous formulations, and are often used in combination with other drugs to treat more severe cases. The dihydropyridine market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more